75.966 Medical Use of Psilocybin and 3, 4-Methylenedioxymethamphetamine (MDMA)
MSSNY awaits FDA evaluation of psilocybin and MDMA clinical trials completed and underway so that scientific data informs judgments about risks and benefits of treatment.
MSSNY will advocate that New York State wait for the FDA to approve psilocybin and MDMA as safe medications with guidance on how they should be prescribed rather than enact legislation to permit their use as medications.
MSSNY supports decriminalization of possession of psilocybin and MDMA for personal use. (HOD 2023-157)
